Jennifer Bae is the Managing Director of Innovation for the American College of Cardiology and built the infrastructure for ACC’s Innovation Program from the ground up. Prior to the ACC, Jennifer worked in global health and pandemic preparedness, including at the Centers for Disease Control and Prevention and the Department of State, where she led Biosecurity Engagement Programs in South and Southeast Asia and served as the Deputy Chief of Bio-engagement globally. She represented the US Government in a Delegation to the United Nations and crafted pandemic preparedness policies with the interagency. Prior to her government service, she led best practice research directed at solving strategic and operational issues for the Advisory Board Company. Jennifer holds a Master’s in Health Services Administration from the University of Michigan School of Public Health. She speaks Mandarin Chinese, Bahasa (Indonesian), and Spanish.
“ACC built its innovation program around the digital transformation of health care delivery, with remote monitoring as a key aspect of that effort,” Bae said. “cliexa’s platform for collecting patient data both during and between medical office visits, with great attention to information security, supports our shared emphasis on improving patient care by collecting meaningful information and representing it in a way that is actionable to clinicians. I am honored to continue working with cliexa and the other board members to move this innovative vision forward.”
Keith Pinter most recently served as Chief Operating Officer for the $6.5B Physician Services group of the Fortune 500 Envision Healthcare. Prior to Envision, Keith was Corporate Vice President for Health Management Associates, a Fortune 500 healthcare provider acquired by Community Health Systems in 2014. Previously, Mr. Pinter functioned as President of Lido Capital, XDrive, Epoch internet, and Ameritech. Mr. Pinter received his Presidential MBA from Pepperdine University in 2007. He currently chairs the University of Miami Data Sciences Executive Advisory Board, as well as serving on the boards of Accolite, Burst IQ, and Bold Destiny.
“I’m excited to assist the board and leadership team in unlocking the tremendous value which cliexa has purposefully and innovatively engineered with its unique platform, enabling providers to make informed decisions more effectively and having a holistic view of patient-reported data. cliexa’s unique platform with clinician-centric workflows, AI-driven predictive risk models and compliance framework has the potential to make a substantial difference for many of the specialties, especially so for those chronic diseases.”, Keith Pinter said,
“cliexa just got two of the best board members and advisor with great experience in healthcare innovation, clinical technology development, and healthcare operations. We are extremely lucky to have Jennifer’s and Keith’s wisdom to accelerate cliexa’s growth moving forward,” said Mehmet Kazgan, Founder and CEO of cliexa.